Dr. Bruce Chabner is a Professor of Medicine at Harvard Medical School and Director of Clinical
Research at the Massachusetts General Hospital Cancer Center.
Dr. Chabner graduated summa cum laude from Yale College in 1961. He received his M.D. from Harvard
University cum laude in 1965 following which he completed an internship and junior residency in internal
medicine at Peter Bent Brigham Hospital in Boston and a senior residency in internal medicine at Yale-
New Haven Medical Center.
Dr. Chabner has had extensive experience in the field of cancer drug discovery and development. After
joining the National Cancer Institute (NCI) as a Senior Investigator in the Laboratory of Chemical
Pharmacology in 1971, he participated in the training of clinical and research fellows there for the
following 24 years, including three years (1976-1979) as Chief of the Clinical Pharmacology Branch; two
years (1979-1981) as Director of the Clinical Oncology Program and its fellowship programs in medical,
pediatric, radiation, and surgical oncology; and, in 1981, one year as Acting Director, and for 13 years as
permanent Director of the Division of Cancer Treatment, NCI.
In 1995, he joined the Massachusetts General Hospital as Clinical Director of its cancer center and Chief
of Hematology/Oncology. With the formation of the Dana-Farber/Harvard Cancer Center, he assumed
responsibilities as Associate Director for Clinical Sciences of that consortium, which includes the
Massachusetts General Hospital, Brigham & Women’s Hospital, Dana-Farber Cancer Institute and Beath
Israel Deaconess Medical Center.